121 related articles for article (PubMed ID: 33853084)
1. Small Intestinal Neuroendocrine Neoplasm: Factors Associated with the Development of Local Tumor-Related Symptoms.
Deguelte S; Metoudi A; Rhaiem R; Hoeffel C; Brixi H; Cadiot G; Kianmanesh R
Neuroendocrinology; 2022; 112(3):252-262. PubMed ID: 33853084
[TBL] [Abstract][Full Text] [Related]
2. Toward a Preoperative Classification of Lymph Node Metastases in Patients with Small Intestinal Neuroendocrine Tumors in the Era of Intestinal-Sparing Surgery.
Lardière-Deguelte S; de Mestier L; Appéré F; Vullierme MP; Zappa M; Hoeffel C; Noaves M; Brixi H; Hentic O; Ruszniewski P; Cadiot G; Panis Y; Kianmanesh R
Neuroendocrinology; 2016; 103(5):552-9. PubMed ID: 26445315
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection.
Laskaratos FM; Liu M; Malczewska A; Ogunbiyi O; Watkins J; Luong TV; Mandair D; Caplin M; Toumpanakis C
Endocrine; 2020 Aug; 69(2):430-440. PubMed ID: 32291735
[TBL] [Abstract][Full Text] [Related]
4. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival.
Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P
JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence angiography guided resection of small bowel neuroendocrine neoplasms with mesenteric lymph node metastases.
Kaçmaz E; Slooter MD; Nieveen van Dijkum EJM; Tanis PJ; Engelsman AF
Eur J Surg Oncol; 2021 Jul; 47(7):1611-1615. PubMed ID: 33353827
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of Radio-Guided Surgery with ⁶⁸Gallium-DOTATATE in Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumors.
Sadowski SM; Millo C; Neychev V; Aufforth R; Keutgen X; Glanville J; Alimchandani M; Nilubol N; Herscovitch P; Quezado M; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S676-82. PubMed ID: 26350374
[TBL] [Abstract][Full Text] [Related]
7. Surgical Principles in the Management of Small Bowel Neuroendocrine Tumors.
Gangi A; Anaya DA
Curr Treat Options Oncol; 2020 Aug; 21(11):88. PubMed ID: 32862334
[TBL] [Abstract][Full Text] [Related]
8. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
9. Predicting symptomatic mesenteric mass in small intestinal neuroendocrine tumors using radiomics.
Blazevic A; Starmans MPA; Brabander T; Dwarkasing RS; van Gils RAH; Hofland J; Franssen GJH; Feelders RA; Niessen WJ; Klein S; de Herder WW
Endocr Relat Cancer; 2021 Jun; 28(8):529-539. PubMed ID: 34003139
[TBL] [Abstract][Full Text] [Related]
10. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
[TBL] [Abstract][Full Text] [Related]
11. Limitations of somatostatin scintigraphy in primary small bowel neuroendocrine tumors.
Maxwell JE; Sherman SK; Menda Y; Wang D; O'Dorisio TM; Howe JR
J Surg Res; 2014 Aug; 190(2):548-53. PubMed ID: 24950794
[TBL] [Abstract][Full Text] [Related]
12. Upfront surgery of small intestinal neuroendocrine tumors. Time to reconsider?
Daskalakis K; Tsolakis AV
World J Gastroenterol; 2018 Aug; 24(29):3201-3203. PubMed ID: 30090001
[TBL] [Abstract][Full Text] [Related]
13. Primary Tumor Resection is Associated with Improved Disease-Specific Mortality in Patients with Stage IV Small Intestinal Neuroendocrine Tumors (NETs): A Comparison of Upfront Surgical Resection Versus a Watch and Wait Strategy in Two Specialist NET Centers.
Levy S; Arthur JD; Banks M; Kok NFM; Fenwick SW; Diaz-Nieto R; van Leerdam ME; Cuthbertson DJ; Valk GD; Kuhlmann KFD; Tesselaar MET
Ann Surg Oncol; 2022 Nov; 29(12):7822-7832. PubMed ID: 35842528
[TBL] [Abstract][Full Text] [Related]
14. Small bowel neuroendocrine tumors: A critical analysis of diagnostic work-up and operative approach.
Ethun CG; Postlewait LM; Baptiste GG; McInnis MR; Cardona K; Russell MC; Kooby DA; Staley CA; Maithel SK
J Surg Oncol; 2016 Nov; 114(6):671-676. PubMed ID: 27511436
[TBL] [Abstract][Full Text] [Related]
15. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumor: Correlations between MRI features, tumor biology, and clinical outcome after surgery.
Canellas R; Lo G; Bhowmik S; Ferrone C; Sahani D
J Magn Reson Imaging; 2018 Feb; 47(2):425-432. PubMed ID: 28480609
[TBL] [Abstract][Full Text] [Related]
17. Surgical Treatment of Small Bowel Neuroendocrine Tumors.
Farley HA; Pommier RF
Hematol Oncol Clin North Am; 2016 Feb; 30(1):49-61. PubMed ID: 26614368
[TBL] [Abstract][Full Text] [Related]
18. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological correlations of mesenteric fibrosis and evaluation of a novel biomarker for fibrosis detection in small bowel neuroendocrine neoplasms.
Laskaratos FM; Mandair D; Hall A; Alexander S; von Stempel C; Bretherton J; Luong T; Watkins J; Ogunbiyi O; Rombouts K; Caplin M; Toumpanakis C
Endocrine; 2020 Mar; 67(3):718-726. PubMed ID: 31598848
[TBL] [Abstract][Full Text] [Related]
20. Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.
Thapa P; Ranade R; Ostwal V; Shrikhande SV; Goel M; Basu S
Nucl Med Commun; 2016 Oct; 37(10):1030-7. PubMed ID: 27243215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
